Life Sciences
FIH Partners advises Nordic Capital on the acquisition of Evosep
Learn more
Life Sciences
FIH Partners advises Coloplast on the acquisition of Kerecis, an innovative fast-growing company in the biologics wound care segment
Learn more
Life Sciences
FIH Partners advises Novo Holdings on the acquisition of Ellab, a global leader in high-end validation and monitoring for the life science industry
Learn more
Life Sciences
Since the dawn of biotech IPOs in Denmark in the mid-1990s, the partners of FIH Partners have been actively advising pharma, medtech, biotech and medical supplies companies.
Over the years, we have developed a detailed understanding of the commercial, scientific and regulatory drivers and risks associated with operating in the sector.
Examples of our experience in healthcare:
- Advisor to Nordic Capital on the acquisition of Evosep, a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics
- Advisor to Coloplast on the acquisition of Kerecis, an innovative fast-growing company in the biologics wound care segment
- Advisor to Novo Holdings on the acquisition of Ellab, a global leader in high-end validation and monitoring for the life science industry
- Advisor to Novo Holdings on the proposed merger of Novozymes and Chr. Hansen to create the leading global biosolutions provide
- Advisor to EQT in the divestment of Fertin Pharma to Philip Morris International
- Advisor to Novo A/S in the agreement with Cinven and Ontario Teachers’ Pension Plan to acquire a substantial minority equity stake in Synlab
- Advisor to Novo A/S in the acquisition of Sonion, a global leader in micro-acoustic technologies used for hearing instruments, for in-ear earphones and in specialty headsets, from Altor Fund III
- Advisor to Ambu, listed on the OMX Nordic exchange, in the acquisition of King Systems, a US subsidiary of UK-listed Consort Medical
- Advisor to Glycom in the acquisition of Vitalys’ manufacturing facility in Denmark
- Advisor to ALK-Abelló in several acquisitions, including the acquisition of Artu Biologicals from Dutch-listed company Fornix BioSciences
- Advisor to Altor Equity Partners in the acquisition of Pulse Medtech from US-based Technitrol
- The partners of FIH Partners advised AP Møller Maersk on the divestment of Maersk Medical (Unomedical) to Nordic Capital
- The partners advised the majority shareholder and board of Radiometer in the divestment of the company to US-based Danaher Corporation
- Also, the partners advised on the IPOs of Bavarian Nordic, Genmab, NeuroSearch and Pharmexa
